IM Cannabis Corp
IMCC2.410USD
-0.110-4.37%
Market hours （ET）Quotes delayed by 15 min
7.44MMarket Cap
LossP/E TTM
More Details of IM Cannabis Corp Company
IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).
Company Info
Ticker SymbolIMCC
Company nameIM Cannabis Corp
IPO dateNov 05, 2019
CEOMr. Eyal Fisher
Number of employees55
Security typeOrdinary Share
Fiscal year-endNov 05
AddressKibbutz Glil Yam
City
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code4690500
Phone14162564202
Websitehttps://imcannabis.com/
Ticker SymbolIMCC
IPO dateNov 05, 2019
CEOMr. Eyal Fisher
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Oren Shuster
Mr. Oren Shuster
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
898.35K
+45.64%
Mr. Shmulik Arbel
Mr. Shmulik Arbel
Independent Director
Independent Director
54.86K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-28.57%
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Eyal Fisher
Mr. Eyal Fisher
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Director
Director
--
--
Mr. Brian Schinderle
Mr. Brian Schinderle
Independent Director
Independent Director
--
--
Mr. Uri Birenberg
Mr. Uri Birenberg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Moti Marcus
Mr. Moti Marcus
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Oren Shuster
Mr. Oren Shuster
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
898.35K
+45.64%
Mr. Shmulik Arbel
Mr. Shmulik Arbel
Independent Director
Independent Director
54.86K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-28.57%
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Eyal Fisher
Mr. Eyal Fisher
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
--
--
Revenue Breakdown
Currency: CADUpdated: Sun, Jul 6
Currency: CADUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
No Data
By RegionCAD
Name
Revenue
Proportion
Germany
7.71M
61.64%
Israel
4.79M
38.36%
Adjustments
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Shuster (Oren)
17.49%
Molho (Ran)
13.74%
Gabay (Rafael)
10.10%
Lustig (Marc)
3.02%
AdvisorShares Investments, LLC
2.03%
Other
53.62%
Shareholders
Shareholders
Proportion
Shuster (Oren)
17.49%
Molho (Ran)
13.74%
Gabay (Rafael)
10.10%
Lustig (Marc)
3.02%
AdvisorShares Investments, LLC
2.03%
Other
53.62%
Shareholder Types
Shareholders
Proportion
Individual Investor
75.95%
Investment Advisor
3.78%
Research Firm
0.09%
Other
20.18%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
37
2.46M
79.82%
+955.09K
2025Q1
38
1.47M
47.74%
-160.92K
2024Q4
42
1.47M
47.79%
+350.95K
2024Q3
48
940.41K
38.51%
-167.62K
2024Q2
52
942.46K
38.60%
-171.69K
2024Q1
56
979.54K
40.26%
-121.50K
2023Q4
56
985.22K
44.75%
-141.95K
2023Q3
65
1.02M
46.98%
-107.12K
2023Q2
70
1.00M
46.23%
+11.21K
2023Q1
70
856.29K
40.02%
-3.03K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Shuster (Oren)
898.35K
29.12%
+281.52K
+45.64%
May 26, 2025
Molho (Ran)
705.67K
22.87%
+705.67K
--
Jun 24, 2025
Gabay (Rafael)
518.52K
16.81%
+128.82K
+33.06%
May 26, 2025
Lustig (Marc)
155.11K
5.03%
--
--
Dec 31, 2024
AdvisorShares Investments, LLC
104.08K
3.37%
--
--
Mar 31, 2025
Arbel (Shmulik)
54.86K
1.78%
--
--
Mar 31, 2025
BMO Nesbitt Burns Inc.
12.48K
0.4%
-106.00
-0.84%
Mar 31, 2025
Zakariya (Einat)
10.20K
0.33%
--
--
Mar 31, 2025
Desjardins Securities Inc.
1.91K
0.06%
-1.89K
-49.71%
Mar 31, 2025
SBI Securities Co., Ltd.
800.00
0.03%
+792.00
+9900.00%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
AdvisorShares Pure Cannabis ETF
2.56%
Amplify Seymour Cannabis ETF
0%
AdvisorShares Pure Cannabis ETF
Proportion2.56%
Amplify Seymour Cannabis ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 09, 2024
Merger
6<1
Jul 09, 2024
Merger
6<1
Jul 09, 2024
Merger
6<1
Jul 09, 2024
Merger
6<1
Nov 15, 2022
Merger
10<1
Nov 15, 2022
Merger
10<1
Date
Type
Ratio
Jul 09, 2024
Merger
6<1
Jul 09, 2024
Merger
6<1
Jul 09, 2024
Merger
6<1
Jul 09, 2024
Merger
6<1
Nov 15, 2022
Merger
10<1
Nov 15, 2022
Merger
10<1
Nov 15, 2022
Merger
10<1
Nov 15, 2022
Merger
10<1
